Mirati vet Christensen was named CEO of Terremoto, a well-funded startup, as the company signals continued emphasis on executive-led commercialization. The management change comes with references to senior leadership transitions and underscores a shift from early technology development toward market-facing execution. The move is consistent with a broader pattern where post-financing startups accelerate product and partnership strategies. Terremoto’s funding and operating focus will be watched for pipeline milestones and business development pace. As biotech teams tighten resource allocation, leadership transitions often determine how quickly platforms translate into trial execution, regulatory planning, and scalable partnerships.